Waters Corporation, a global leader in analytical instruments and software, has completed the acquisition of Wyatt Technology. Wyatt Technology is a recognized leader in innovative light scattering and field-flow fractionation instruments, software, accessories, and services. The acquisition positions Waters to better serve the fast-growing needs of its global customers in cellular and gene therapies, which represents a significant opportunity with a $1.8 billion total addressable market and 10-12% projected annual growth. The transaction is expected to be immediately accretive to Waters’ revenue growth and margin profile, generating over $70 million in annual revenue synergies by the fifth year following transaction close.
Related Facts:
– Wyatt Technology’s instruments are used to determine the absolute molar mass, size, charge, and interactions of macromolecules and nanoparticles in solution.
– The company’s scientists invented the very first commercial light scattering detectors incorporating lasers as their light source.
– Waters operates directly in 35 countries, including 14 manufacturing facilities, and with products available in more than 100 countries.
– With more than 80% of Wyatt’s rapidly growing revenues tied to large molecule applications, the acquisition accelerates Waters’ ability to build a high-growth business in bioanalytical characterization for new modalities.
Key Takeaway:
The acquisition of Wyatt Technology is a significant milestone for Waters as it advances its strategy to accelerate value creation and generate faster growth. With Wyatt, Waters is even better positioned to solve its customers’ critical challenges with differentiated bioanalytical characterization techniques. The acquisition is expected to generate over $70 million in annual revenue synergies by the fifth year following transaction close, with the transaction being immediately accretive to Waters’ revenue growth and margin profile.
Conclusion:
The acquisition of Wyatt Technology is expected to be a game-changer for Waters Corporation as it seeks to expand its presence in the bioanalytical characterization space. Waters’ global reach and expertise in simplifying sophisticated techniques for high-volume applications, along with Wyatt’s highly complementary analytical technologies, positions the company to better serve the fast-growing needs of its global customers. The acquisition is expected to generate significant revenue synergies, providing a boost to Waters’ revenue growth and margin profile.
